Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial. J Thromb Haemost. 2015 Dec; 13(12):2187-91.